Eugeniin improves cholesterol metabolism in HepG2 cells and Caco-2 cells

被引:3
|
作者
Ye, Yuyang [1 ]
Takeuchi, Asahi [1 ]
Kawaguchi, Yuya [1 ]
Matsuba, Shoya [1 ]
Zhang, Ni [1 ]
Mijiti, Maihemuti [1 ]
Banno, Arata [1 ]
Hiramatsu, Naoto [2 ]
Okada, Toshitaka [2 ]
Nagaoka, Satoshi [1 ]
机构
[1] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Gifu, Japan
[2] Toyohakko Co Ltd, Dept Res & Dev, Obu, Aichi, Japan
关键词
eugeniin; LDL; HepG2; cells; cholesterol; Caco-2; HYPERCHOLESTEROLEMIA; ABSORPTION; HMGCR;
D O I
10.1093/bbb/zbad158
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Considering the absence of prior studies on the cholesterol metabolism-improving effects of eugeniin, the present investigation aimed to explore the potential impact of eugeniin on cholesterol metabolism. This study sought to elucidate the molecular mechanisms involved in this process using HepG2 and Caco-2 cells treated with 5 mu m eugeniin. The intracellular cholesterol levels in HepG2 and Caco-2 cells were significantly decreased in the 24-h eugeniin-treated group. The protein and messenger ribonucleic acid (mRNA) levels of the low-density lipoprotein receptor (LDLR) were increased, while 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase protein and mRNA levels were decreased in HepG2 cells 6 h of the eugeniin-treated group. Additionally, LDLR protein and mRNA levels were increased in HepG2 cells after 24 h of eugeniin treatment. In Caco-2, the protein and mRNA levels of ATP-binding cassette transporter 1 were increased after 24 h eugeniin treatment. This novel finding indicates that eugeniin improves cholesterol metabolism in human cell cultures. Graphical Abstract Mechanism of action to improve cholesterol metabolism by eugeniin in HepG2 cells and Caco-2 cells.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 50 条
  • [21] YDFYPSSTKDQQS (P3), a peptide from lupin protein, absorbed by Caco-2 cells, modulates cholesterol metabolism in HepG2 cells via SREBP-1 activation
    Lammi, Carmen
    Zanoni, Chiara
    Arnoldi, Anna
    Aiello, Gilda
    JOURNAL OF FOOD BIOCHEMISTRY, 2018, 42 (03)
  • [22] PPARγ ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2
    Klopotek, Anett
    Hirche, Frank
    Eder, Klaus
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (08) : 1365 - 1372
  • [23] In vitro biotransformation of ochratoxin A using a co-culture system with Caco-2 and HepG2 cells
    Gonzalez-Arias, C. A.
    Marin, S.
    Rojas-Garcia, A. E.
    Sanchis, V.
    Ramos, A. J.
    TOXICOLOGY LETTERS, 2016, 259 : S136 - S136
  • [24] Investigation of the cytotoxicity of food-grade nanoemulsions in Caco-2 cell monolayers and HepG2 cells
    Yu, Hailong
    Huang, Qingrong
    FOOD CHEMISTRY, 2013, 141 (01) : 29 - 33
  • [25] Dual action of sulforaphane in the regulation of thioredoxin reductase and thioredoxin in human HepG2 and Caco-2 cells
    Bacon, James R.
    Plumb, Geoff W.
    Howie, A. Forbes
    Beckett, Geoffrey J.
    Wang, Wei
    Bao, Yongping
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2007, 55 (04) : 1170 - 1176
  • [26] Effect of micellar beta-sitosterol on cholesterol metabolism in CaCo-2 cells
    Field, FJ
    Born, E
    Mathur, SN
    JOURNAL OF LIPID RESEARCH, 1997, 38 (02) : 348 - 360
  • [27] REGULATION OF CHOLESTEROL ESTERIFICATION BY MICELLAR CHOLESTEROL IN CACO-2 CELLS
    FIELD, FJ
    ALBRIGHT, E
    MATHUR, SN
    JOURNAL OF LIPID RESEARCH, 1987, 28 (09) : 1057 - 1066
  • [28] POLYAMINE METABOLISM AND DIFFERENTIATION IN CACO-2 CELLS
    HALLINE, AG
    DUDEJA, PK
    BRASITUS, TA
    MUSCH, MW
    CHANG, EB
    GASTROENTEROLOGY, 1988, 94 (05) : A169 - A169
  • [29] Kinetics of homocysteine metabolism in Caco-2 cells
    Townsend, JH
    Davis, SR
    Mackey, AD
    Gregory, JF
    FASEB JOURNAL, 2003, 17 (04): : A309 - A309
  • [30] Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells
    Leng, Ennian
    Xiao, Yuan
    Mo, Zhentao
    Li, Yiqi
    Zhang, Yueyue
    Deng, Xiaosi
    Zhou, Min
    Zhou, Chaochao
    He, Zengxuan
    He, Jingyi
    Xiao, Lu
    Li, Junming
    Li, Wenna
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 18